VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were down 11.8% on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. Approximately 222,895 shares were traded during mid-day trading, a decline of 24% from the average daily volume of 293,391 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 9.1 %
The firm has a 50 day moving average of C$0.11 and a two-hundred day moving average of C$0.13. The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56. The stock has a market capitalization of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- The Basics of Support and Resistance
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Ride Out The Recession With These Dividend Kings
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
